Related Experiment Videos
High sensitivity C-reactive protein
1Coagulation Service of the University of Alabama at Birmingham Hospital, USA. gfritsma@mindspring.com
Insights
High-sensitivity C-reactive protein (hsCRP) effectively predicts cardiovascular disease risk in healthy adults, especially with other markers. However, hsCRP may be less useful in hospitalized patients due to inflammation.
Area of Science:
- Cardiovascular Medicine
- Clinical Chemistry
Background:
- Cardiovascular disease (CVD) remains a leading cause of mortality worldwide.
- Accurate risk stratification is crucial for effective CVD prevention strategies.
Purpose of the Study:
- To evaluate the utility of high-sensitivity C-reactive protein (hsCRP) as a cardiovascular disease risk marker.
- To assess the role of hsCRP in conjunction with other established risk biomarkers.
Main Methods:
- Analysis of hsCRP levels in relation to cardiovascular events.
- Comparative assessment of hsCRP with fibrinogen, homocysteine, and lipid assays.
- Evaluation of hsCRP performance in healthy adults versus inpatient populations.
Main Results:
- hsCRP demonstrates significant potential as a standalone cardiovascular disease risk predictor in healthy adults.
- Combined use of hsCRP with other markers like fibrinogen and lipid assays enhances predictive accuracy.
- hsCRP utility may be limited in inpatients due to elevated levels caused by acute inflammatory conditions.
Conclusions:
- hsCRP is a valuable marker for identifying cardiovascular disease risk, particularly in asymptomatic individuals.
- The integration of hsCRP testing into routine cardiovascular risk assessments can improve patient management.
- Further research into hsCRP's role in diverse clinical settings is warranted.
Abstract:
Though there is no apparent relationship between CRP and cardiovascular disease, the hsCRP may be the most effective single marker of disease among otherwise healthy adults, and is certainly an effective marker when employed in combination with other proven markers such as fibrinogen, homocysteine, and lipid assays. The hsCRP test may not be particularly useful among inpatients, however, as it is typically elevated in acute inflammatory disease. In addition to its apparent ability to predict the risk of cardiovascular disease, the hsCRP test points the way to further identification of risk markers.